Analysts Set Crocs, Inc. (NASDAQ:CROX) Price Target at $139.10

Crocs, Inc. (NASDAQ:CROXGet Free Report) has been given an average recommendation of “Moderate Buy” by the twenty brokerages that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokers that have covered the stock in the last year is $139.10.

CROX has been the topic of a number of research reports. Barclays upped their target price on Crocs from $110.00 to $118.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Piper Sandler reaffirmed an “overweight” rating on shares of Crocs in a research report on Friday, July 31st. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Crocs in a research note on Monday, June 8th. They issued a “buy” rating on the stock. Needham & Company LLC boosted their price target on shares of Crocs from $132.00 to $150.00 and gave the company a “buy” rating in a report on Friday, July 24th. Finally, Seaport Research Partners upped their price target on shares of Crocs from $135.00 to $160.00 and gave the stock a “buy” rating in a research note on Monday, July 20th.

Read Our Latest Stock Report on Crocs

Crocs Price Performance

CROX opened at $116.01 on Friday. The stock has a fifty day moving average of $128.88 and a 200-day moving average of $110.60. The firm has a market capitalization of $5.56 billion, a P/E ratio of 10.03, a PEG ratio of 0.97 and a beta of 1.52. Crocs has a 12-month low of $73.21 and a 12-month high of $141.28. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.94.

Crocs (NASDAQ:CROXGet Free Report) last issued its quarterly earnings results on Thursday, July 30th. The textile maker reported $4.55 earnings per share for the quarter, beating analysts’ consensus estimates of $4.35 by $0.20. The business had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.15 billion. Crocs had a return on equity of 47.75% and a net margin of 14.64%.Crocs’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($8.82) earnings per share. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. Equities analysts forecast that Crocs will post 13.95 EPS for the current fiscal year.

Insider Buying and Selling

In other Crocs news, CEO Andrew Rees sold 19,072 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $138.91, for a total value of $2,649,291.52. Following the transaction, the chief executive officer directly owned 713,293 shares of the company’s stock, valued at $99,083,530.63. This represents a 2.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On Crocs

A number of hedge funds have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Crocs by 159.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 746 shares of the textile maker’s stock worth $79,000 after acquiring an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Crocs by 4.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 211,305 shares of the textile maker’s stock valued at $22,441,000 after purchasing an additional 8,331 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Crocs by 278.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 862 shares of the textile maker’s stock valued at $87,000 after purchasing an additional 634 shares in the last quarter. First Trust Advisors LP lifted its stake in shares of Crocs by 14.3% in the 2nd quarter. First Trust Advisors LP now owns 112,217 shares of the textile maker’s stock valued at $11,365,000 after purchasing an additional 14,067 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in Crocs in the second quarter worth $6,290,000. Institutional investors and hedge funds own 93.44% of the company’s stock.

About Crocs

(Get Free Report)

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.

See Also

Analyst Recommendations for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.